SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-24-002002
Filing Date
2024-10-15
Accepted
2024-10-15 16:44:28
Documents
14
Period of Report
2024-10-09
Items
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20241009.htm   iXBRL 8-K 25031
  Complete submission text file 0001096906-24-002002.txt   158600

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20241009_def.xml EX-101.DEF 1842
3 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20241009_lab.xml EX-101.LAB 20750
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20241009_pre.xml EX-101.PRE 13772
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20241009.xsd EX-101.SCH 2304
16 EXTRACTED XBRL INSTANCE DOCUMENT axim-20241009_htm.xml XML 2676
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 241372375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)